JERSEY GPs have sounded the alarm about the “significant clinical risks” that come from sourcing weight‑loss drugs online without medical supervision – warning that these “unregulated products” could ...

Several oncology companies announced key trial milestones this week across the landscape of both blood cancers and solid ...

Kodiak Sciences' pipeline, led by tarcocimab, targets less frequent dosing for retinal diseases but faces tough competition ...

German troops in WWII were dosed with Pervitin, a methamphetamine that kept them awake, fearless, and relentless. But the ...

The trial’s primary goal is to evaluate the tolerability and safety of the therapy in paediatric patients with achondroplasia ...

Interius is working on a more efficient way to deliver CAR-T therapy to patients. Unlock Digital Access for unlimited access to Inquirer.com and The Inquirer App, plus 5 articles per month to gift to ...

Mesutoclax is a novel, orally bioavailable BCL2 selective inhibitor. BCL2 is an important regulatory protein in the apoptosis pathway, and its abnormal expression is associated with the development of ...

First Patients Dosed on Expansion Study of NUC-7738 in Combination with Pembrolizumab for Patients with PD-1 Inhibitor-Resistant Melanoma ...

In the letters, Paxton’s office demanded that Her Safe Harbor, Plan C and Coeytaux stop mailing abortion pills into Texas. The attorney general also threatened civil penalties of up to $100,000 per ...

The idea behind the tolerogenic nanoparticle treatment, CNP-103, is to reprogram the inflammatory autoimmune response that ...

The FDA has granted regenerative medicine advanced therapy designation to BEAM-101, a one-time, gene-edited cell therapy for ...